Globus Medical (GMED) Tops Q4 EPS by 4c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/21/2026
- AI stocks lift Wall St as oil falls, Treasury yields decline
- Oil prices slide to 11-day low on hopes of US-Iran diplomacy, Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
- Far-left party wins Berlin election, pledging to nationalise housing
- Cybercrime feud erupts on dark web as notorious group claims hijack of rival's website
- Qatar Investment Authority targets $20B partnership with JPMorgan - Bloomberg
- AMD stock jumps as chip rally builds ahead of summit
- Novo Nordisk shares drop as investor event disappoints
Globus Medical Reports Full Year and Fourth Quarter 2018 Results
February 21, 2019 4:16 PM ESTAUDUBON, Pa., Feb. 21, 2019 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced its financial results for the fourth quarter and year ended December 31, 2018.
Fourth Quarter:
Worldwide sales increased 11.3% as reported to $195.9 millionFourth quarter net income was $36.8 million, or 18.8% of sales.Diluted earnings per share (EPS) were $0.36Non-GAAP diluted EPS were $0.43Non-GAAP adjusted EBITDA was 34.1% of salesFull Year 2018:
Worldwide sales increased 12.1% as reported to $713.0 millionNet income... More